Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1972 Sep;2(3):201–205. doi: 10.1128/aac.2.3.201

Inhibition of Vesicular Stomatitis Virus Replication by 9-β-d-Arabinofuranosyladenine

J A Grant 1, L R Sabina 1
PMCID: PMC444291  PMID: 4364172

Abstract

9-β-d-Arabinofuranosyladenine (Ara-A) effectively inhibited the production of infectious vesicular stomatitis virus (VSV) in MDBK cells. Furthermore, inhibition was shown to begin as early as the first 3 hr of infection. Studies employing 3H-l-leucine indicated that Ara-A did not affect protein synthesis in uninfected cells, although it did cause a marked stimulation of protein synthesis in VSV-infected cells during the log phase of the growth cycle. Puromycin, an inhibitor of protein synthesis, was a more effective viral inhibitor than Ara-A. However, the combination of Ara-A and puromycin was less effective than puromycin alone except when present for long time periods. Short-term labeling experiments with 3H-uridine demonstrated that Ara-A depressed ribonucleic acid (RNA) synthesis in uninfected cells, whereas periods of stimulation and depression of radioisotope incorporation occurred in infected cells. The results support the notion that Ara-A is incorporated into RNA early during viral replication.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRINK J. J., LEPAGE G. A. 9-BETA-D-ARABINOFURANOSYLADENINE AS AN INHIBITOR OF METABOLISM IN NORMAL AND NEOPLASTIC CELLS. Can J Biochem. 1965 Jan;43:1–15. doi: 10.1139/o65-001. [DOI] [PubMed] [Google Scholar]
  2. Baltimore D., Huang A. S., Stampfer M. Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci U S A. 1970 Jun;66(2):572–576. doi: 10.1073/pnas.66.2.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. EAGLE H. Amino acid metabolism in mammalian cell cultures. Science. 1959 Aug 21;130(3373):432–437. doi: 10.1126/science.130.3373.432. [DOI] [PubMed] [Google Scholar]
  4. Freeman G., Kuehn A., Sultanian I. Tumorigenic virus and cell responses to biologically active compounds. II. Pharmacologic specificity in cell-virus relationships. Ann N Y Acad Sci. 1965 Jul 30;130(1):330–342. doi: 10.1111/j.1749-6632.1965.tb12567.x. [DOI] [PubMed] [Google Scholar]
  5. HUBERT-HABART M., COHEN S. S. The toxicity of 9-beta-D-arabinofuranosyladenine to purine-requiring Escherichia coli. Biochim Biophys Acta. 1962 May 21;59:468–471. doi: 10.1016/0006-3002(62)90198-1. [DOI] [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Miller F. A., Dixon G. J., Ehrlich J., Sloan B. J., McLean I. W., Jr Antiviral activity of 9-beta-D-arabinofuranosyladenine. I. Cell culture studies. Antimicrob Agents Chemother (Bethesda) 1968;8:136–147. [PubMed] [Google Scholar]
  8. PRIVATDEGARILHE M., DE RUDDER J. EFFET DE DEUX NUCL'EOSIDES DE L'ARABINOSE SUR LA MULTIPLICATION DES VIRUS DE L'HERP'ES ET DE LA VACCINE EN CULTURE CELLULAIRE. C R Hebd Seances Acad Sci. 1964 Oct 19;259:2725–2728. [PubMed] [Google Scholar]
  9. Sabina L. R., Munro T. W. Effects of trypsin on replication of parainfluenza-3 virus in HEp-2 cell cultures. Can J Microbiol. 1969 Jun;15(6):577–582. doi: 10.1139/m69-098. [DOI] [PubMed] [Google Scholar]
  10. Schabel F. M., Jr The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A). Chemotherapy. 1968;13(6):321–338. doi: 10.1159/000220567. [DOI] [PubMed] [Google Scholar]
  11. Warner A. H., McClean D. K. Studies on the biosynthesis and role of diguanosine tetraphosphate during growth and development of Artemia salina. Dev Biol. 1968 Sep;18(3):278–293. doi: 10.1016/0012-1606(68)90036-5. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES